Profile data is unavailable for this security.
About the company
Arterra Bioscience SpA is an Italy-based biotechnology company. The Company focuses on research and development of ingredients and natural solutions. By exploiting the potentialities of living organisms such as bacteria, yeasts, plants and animal cells, the Company develops products and processes that serve as enabling technologies and that find horizontal application in various industrial sectors, such as cosmetics, agriculture and nutraceutics. The Company’s main activities and applications include development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds and the production of high-tech raw materials with application in different industrial fields. The Company collaborates with private companies, universities and research institutes all over the world.
- Revenue in EUR (TTM)4.49m
- Net income in EUR1.90m
- Incorporated--
- Employees37.00
- LocationArterra Bioscience SpAvia Benedetto Brin, 69NAPOLI 80142ItalyITA
- Websitehttps://www.arterrabio.it
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gensight Biologics SA | 194.00k | -15.12m | 18.40m | 13.00 | -- | -- | -- | 94.85 | -0.1293 | -0.1293 | 0.0016 | -0.245 | 0.0174 | -- | 10.78 | 16,166.67 | -135.38 | -81.19 | -- | -203.71 | -- | -- | -7,793.81 | -868.76 | -- | -- | -- | -- | 18.39 | 16.47 | 46.60 | -- | -57.94 | -- |
| Urteste SA | 0.00 | -1.30m | 18.48m | 34.00 | -- | 3.32 | -- | -- | -3.88 | -3.88 | 0.00 | 15.35 | 0.00 | -- | -- | -- | -15.56 | -29.65 | -18.99 | -31.35 | -- | -45,933.33 | -- | -623,333.30 | -- | -- | 0.0128 | -- | -- | -- | 35.00 | -- | 197.79 | -- |
| Hyenergy SA | 781.05k | 40.33k | 18.50m | 27.00 | -- | 3.95 | 318.90 | 23.69 | -0.0936 | -0.0936 | 0.1654 | 0.5878 | 0.1821 | 0.1259 | 0.7741 | -- | 0.9403 | 2.39 | 1.28 | 3.35 | 99.70 | 77.46 | 5.16 | 3.11 | 1.30 | 1.17 | 0.00 | -- | 192.83 | 19.47 | 100.30 | -- | -45.79 | -- |
| Klaria Pharma Holding AB (publ) | 1.06m | -5.54m | 19.14m | 4.00 | -- | 44.60 | -- | 18.04 | -0.4069 | -0.3093 | 0.0699 | 0.0185 | 0.201 | -- | 5.34 | 2,808,250.00 | -105.02 | -48.20 | -649.38 | -74.06 | -- | -- | -522.58 | -1,522.52 | -- | -2.47 | 0.1195 | -- | -73.41 | -11.85 | -33.44 | -- | -- | -- |
| Initiator Pharma A/S | 0.00 | -1.55m | 19.24m | 2.00 | -- | 4.44 | -- | -- | -0.2729 | -0.2729 | 0.00 | 0.671 | 0.00 | -- | -- | 0.00 | -43.00 | -67.58 | -46.15 | -73.43 | -- | -- | -- | -- | -- | -- | 0.0619 | -- | -- | -- | 53.32 | -- | -- | -- |
| Xbrane Biopharma AB | 19.74m | -6.88m | 19.50m | 26.00 | -- | 0.3517 | -- | 0.9875 | -5.16 | 8.99 | 14.57 | 28.49 | 0.2713 | 0.2899 | 5.00 | 3,216,539.00 | -9.46 | -37.48 | -15.30 | -65.13 | 71.25 | -- | -34.85 | -233.69 | 1.71 | -1.49 | 0.00 | -- | -16.76 | -- | 17.70 | -- | 113.17 | -- |
| Dextech Medical AB | 0.00 | -468.44k | 19.90m | 1.00 | -- | 8.81 | -- | -- | -0.2684 | -0.2684 | 0.00 | 1.29 | 0.00 | -- | -- | 0.00 | -18.58 | -19.36 | -18.94 | -19.80 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -2.96 | -- | 40.14 | -- |
| Arterra Bioscience SpA | 4.49m | 1.90m | 20.24m | 37.00 | 10.11 | 1.65 | 9.10 | 4.50 | 0.3008 | 0.3008 | 0.7097 | 1.84 | 0.3385 | 1.37 | 4.10 | 132,186.50 | 14.35 | 10.33 | 15.55 | 11.35 | 63.60 | 59.90 | 42.38 | 34.18 | 6.31 | -- | 0.0258 | -- | 26.30 | 9.02 | 24.21 | 9.29 | -16.17 | -- |
| Helyx Industries SpA | 925.86k | -5.30m | 20.32m | 23.00 | -- | 0.8991 | 305.09 | 21.95 | -0.205 | -0.205 | 0.0359 | 0.8675 | 0.0345 | 0.9108 | 2.74 | 40,254.78 | -19.77 | -19.75 | -21.32 | -21.62 | -86.89 | -213.90 | -572.63 | -740.61 | 1.48 | -311.98 | 0.0451 | -- | 1,059.84 | 134.89 | -23.83 | -- | -10.84 | -- |
| Solvonis Therapeutics PLC | 0.00 | -2.99m | 20.36m | -- | -- | 2.22 | -- | -- | -0.001 | -0.001 | 0.00 | 0.0012 | 0.00 | -- | -- | -- | -44.49 | -- | -54.32 | -- | -- | -- | -- | -- | -- | -645.25 | 0.011 | -- | -100.00 | -- | 53.62 | -- | -- | -- |
| AlzeCure Pharma AB | 0.00 | -3.70m | 20.62m | 11.00 | -- | 4.31 | -- | -- | -0.4047 | -0.4047 | 0.00 | 0.4409 | 0.00 | -- | -- | 0.00 | -71.83 | -73.70 | -88.08 | -83.65 | -- | -- | -- | -- | -- | -- | 0.053 | -- | -- | -- | 5.20 | -- | -38.94 | -- |
| Nanogroup SA | -1.64k | -1.65m | 20.81m | -- | -- | 7.51 | -- | -- | -0.1844 | -0.1844 | -0.0002 | 0.3553 | -0.0003 | 2.64 | -- | -- | -30.59 | -29.50 | -51.55 | -33.80 | -- | 66.72 | -- | -2,258.26 | 0.9785 | -464.18 | 0.00 | -- | 3.96 | -64.09 | 34.50 | -- | 3.07 | -- |
| Promimic AB | 4.30m | -1.15m | 21.14m | 18.00 | -- | 3.67 | -- | 4.91 | -0.6388 | -0.6388 | 2.40 | 3.23 | 0.603 | -3.56 | 3.62 | 2,398,421.00 | -16.05 | -20.50 | -18.57 | -24.44 | 105.07 | 104.49 | -26.62 | -59.75 | 3.52 | -- | 0.00 | -- | 18.63 | 50.25 | -36.09 | -- | -- | -- |
| Fusion Antibodies PLC | 1.84m | -1.69m | 21.21m | 24.00 | -- | 23.09 | -- | 11.55 | -0.0144 | -0.0144 | 0.0152 | 0.0064 | 0.9557 | 4.96 | 1.96 | 66,500.00 | -87.84 | -56.24 | -137.88 | -73.67 | 22.06 | 36.41 | -91.92 | -71.05 | 1.45 | -190.63 | 0.3483 | -- | 72.98 | -12.79 | 23.05 | -- | -37.98 | -- |
| Sprint Bioscience AB | 4.68m | -2.42m | 21.62m | 29.00 | -- | 37.76 | -- | 4.62 | -0.2986 | -0.2986 | 0.5832 | 0.0575 | 1.47 | -- | 6.02 | 1,303,316.00 | -76.04 | -60.40 | -262.43 | -100.72 | 61.94 | 57.87 | -51.79 | -87.25 | -- | -36.01 | 0.00 | -- | 30.02 | 14.37 | -4,072.83 | -- | 69.39 | -- |
| Circio Holding ASA | 0.00 | -815.80k | 22.33m | 9.00 | 9.64 | -- | -- | -- | 0.1348 | 0.1348 | 0.00 | -0.0836 | 0.00 | -- | -- | 0.00 | -93.87 | -47.84 | -- | -58.78 | -- | -- | -- | -6,460.26 | -- | -- | -- | -- | -100.00 | -- | 150.93 | -- | 7.12 | -- |
Data as of Feb 16 2026. Currency figures normalised to Arterra Bioscience SpA's reporting currency: Euro EUR
0.14%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Banca Finnat Euramerica SpA (Investment Management)as of 30 Sep 2025 | 9.00k | 0.14% |
Data from 30 Sep 2025 - 30 Sep 2025Source: FactSet Research Systems Inc.
